1.
Ersi Voskaridou, Dimitrios Christoulas, Marialena Konstantinidou, Evangelos Tsiftsakis, Panagiotis Alexakos, Evangelos Terpos. Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. haematol [Internet]. 2008Sep.30 [cited 2024Apr.24];93(10):1588-90. Available from: https://haematologica.org/article/view/5047